Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lider

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|March 1, 1989
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparinsO Lider, E Baharav, Y A Mekori, et al.
The Journal of Surgical Research|June 29, 1999
Prolongation of rat skin and cardiac allograft survival by low molecular weight heparinO M Shapira, H Rene, O Lider, et al.
Liver|February 10, 1998
Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in miceH Shirin, R Bruck, H Aeed, et al.
The Journal of Experimental Medicine|November 9, 2000
Autocrine secretion of interferon gamma negatively regulates homing of immature B cellsL Flaishon, R Hershkoviz, F Lantner, et al.
Journal of Leukocyte Biology|June 19, 2001
Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrixG G Vaday, S Franitza, H Schor, et al.
The American Journal of Physiology|July 1, 1997
Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesionR Hershkoviz, L Preciado-Patt, O Lider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
Nonencephalitogenic CD4-CD8- V alpha 2V beta 8.2+ anti-myelin basic protein rat T lymphocytes inhibit disease inductionO Lider, A Miller, S Miron, et al.
The Journal of Clinical Investigation|February 1, 1994
Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretionA Achiron, R Margalit, R Hershkoviz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanaseO Lider, L Cahalon, D Gilat, et al.
Journal of the American Academy of Dermatology|April 29, 1998
Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary reportE Hodak, G Yosipovitch, M David, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|March 1, 1989
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparinsO Lider, E Baharav, Y A Mekori, et al.
The Journal of Surgical Research|June 29, 1999
Prolongation of rat skin and cardiac allograft survival by low molecular weight heparinO M Shapira, H Rene, O Lider, et al.
Liver|February 10, 1998
Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in miceH Shirin, R Bruck, H Aeed, et al.
The Journal of Experimental Medicine|November 9, 2000
Autocrine secretion of interferon gamma negatively regulates homing of immature B cellsL Flaishon, R Hershkoviz, F Lantner, et al.
Journal of Leukocyte Biology|June 19, 2001
Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrixG G Vaday, S Franitza, H Schor, et al.
The American Journal of Physiology|July 1, 1997
Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesionR Hershkoviz, L Preciado-Patt, O Lider, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
Nonencephalitogenic CD4-CD8- V alpha 2V beta 8.2+ anti-myelin basic protein rat T lymphocytes inhibit disease inductionO Lider, A Miller, S Miron, et al.
The Journal of Clinical Investigation|February 1, 1994
Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretionA Achiron, R Margalit, R Hershkoviz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanaseO Lider, L Cahalon, D Gilat, et al.
Journal of the American Academy of Dermatology|April 29, 1998
Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary reportE Hodak, G Yosipovitch, M David, et al.
Pageof 10